-
ICD-10-CM Codes
›
-
Z00-Z99
Factors influencing health status and contact with health services
›
-
Z14-Z15
Genetic carrier and genetic susceptibility to disease
›
-
Z15-
Genetic susceptibility to disease
›
-
2020 ICD-10-CM Diagnosis Code Z15.0
2020 ICD-10-CM Diagnosis Code Z15.0
Genetic susceptibility to malignant neoplasm
2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
- Z15.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2020 edition of ICD-10-CM Z15.0 became effective on October 1, 2019.
- This is the American ICD-10-CM version of Z15.0 - other international versions of ICD-10 Z15.0 may differ.
Use AdditionalUse Additional Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
Code FirstCode First Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
The following code(s) above
Z15.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
Z15.0:
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
Code annotations containing back-references to Z15.0:
ICD-10-CM Codes Adjacent To Z15.0
Z13.88 Encounter for screening for disorder due to exposure to contaminants
Z13.89 Encounter for screening for other disorder
Z13.9 Encounter for screening, unspecified
Z14.0 Hemophilia A carrier
Z14.01 Asymptomatic hemophilia A carrier
Z14.02 Symptomatic hemophilia A carrier
Z14.1 Cystic fibrosis carrier
Z14.8 Genetic carrier of other disease
Z15 Genetic susceptibility to disease
Z15.0
Genetic susceptibility to malignant neoplasm
Z15.09 Genetic susceptibility to other malignant neoplasm
Z15.8 Genetic susceptibility to other disease
Z15.81 Genetic susceptibility to multiple endocrine neoplasia [MEN]
Z15.89 Genetic susceptibility to other disease
Z16 Resistance to antimicrobial drugs
Z16.1 Resistance to beta lactam antibiotics
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
